Systemic GHK-Cu does different things from locally applied GHK-Cu, and the dose-response curves are different
This openness leads to more honest conversations about stress, sleep quality, recovery capacity, and previous treatment experiences that directly shape protocol decisions
[9] In summary, while NAD+ Injection is a broadly applicable metabolic therapy, it should not be used by anyone allergic to it, and it is generally avoided in pregnant women, cancer patients, or those with serious chronic diseases, absent compelling medical rationale
Heres what happens during processing: Your liver metabolizes 90% of acetaminophen through safe glucuronidation pathways CYP2E1 converts a small fraction into harmful NAPQI Alcohol competes for CYP2E1 while present, temporarily blocking NAPQI formation After alcohol clears (6-7 hours), CYP2E1 activity peaks, increasing NAPQI production This biphasic response creates a critical window